A convincing report is not enough. It must be auditable.
These are the standards Aevum Pet is being built to across sample handling, evidence, interpretation and veterinary boundaries.
Laboratory and sample quality
Partner sequencing workflows must document sample identity, coverage, quality thresholds and limitations before a result enters a report.
- Target 30× whole-genome coverage
- Sample and pipeline quality controls
- Confirmation pathways for weighty findings
Species-specific evidence sources
Every interpretation records the dog or cat database, publication and version behind it; human evidence is not silently treated as pet evidence.
- Species-specific evidence first
- Breed and population limitations shown
- Source version retained per report
Interpretation governance
Confidence rules separate established findings from emerging associations and research-only signals.
- Explicit evidence tiers
- No forced certainty from weak data
- Re-review when meaningful evidence changes
Software and AI
Software may organise, connect and explain evidence. It does not create measurements or independently diagnose an animal.
- Grounded in source data
- Deterministic reported values
- Model and interpretation versions recorded
Veterinary hand-off
Findings with possible care implications are framed for professional review, not converted into owner-directed treatment.
- No prescribing or diagnosis
- Confirmation where appropriate
- Clear escalation and referral language
These are development standards, not claims of certifications, regulatory approvals, contracted partners or completed validations.